Target intelligence / Profile preview

Escherichia coli surface antigen (null)

Target
null
Molecular classification
Other (includes diverse structures: polysaccharides, proteins, glycolipids, pili/fimbriae), Polysaccharide antigen (O antigen, K antigen/capsule), Lipopolysaccharide (O antigen), Protein adhesin (fimbriae/pili, Antigen 43/Ag43), Flagellar protein antigen (H antigen), Pilus/fimbrial structure (e.g., CS26 pilus)
01

Overview

Escherichia coli surface antigens comprise a group of structurally and functionally diverse molecules present on the bacterial outer membrane and cell surface. The main classes include the O antigen (the outer polysaccharide of lipopolysaccharide), the K antigen (capsular polysaccharides), the H antigen (flagellin of the bacterial flagella), and a variety of fimbrial or pilus proteins (including specific adhesins such as Antigen 43 and CS26). These antigens are key determinants of pathogenesis, enabling immune evasion, environmental protection, biofilm formation, and tissue adhesion. They are also central to serotyping, strain discrimination, and the development of diagnostic and immunotherapeutic strategies. The term "surface antigens" encapsulates multiple unrelated molecular families, making it a conceptually broad and technically imprecise target for therapeutic intervention.

Other names
E. coli surface antigensE. coli O antigenE. coli K antigenE. coli H antigenE. coli fimbriae (pili)E. coli capsuleEscherichia coli LPS (for the O antigen-containing outer membrane lipopolysaccharide)
02

Mechanism of action

For vaccines or antibodies: Antigen-specific immune targeting—neutralization, opsonization, or complement activation against surface-exposed antigenic structures. Phages: Recognition and binding to surface antigens as receptors. Inhibitors of biosynthesis (in development): Block biosynthetic pathways for O antigen, capsule, or pili

03

Biological functions

Immune evasion (e.g., K antigen/capsule inhibits phagocytosis)Biofilm formation (fimbriae/adhesins, Ag43)Adhesion to host tissues (fimbriae, pili such as CS26)Antigenic variation (diverse O, K, and H antigen variants enable immune escape)Serum resistance and environmental protection (capsule/O antigen)
04

Disease associations

Infection (major role in E. coli pathogenesis)Immune evasion and dissemination in hostOther (enabling colonization and persistence in various niches)
05

Safety considerations

High antigenic variability—immune escape and diagnostic challengesCross-reactivity with commensal or environmental strainsPotential for autoimmunity or unintended immune responses with poorly characterized antigensDifficulty in developing pan-E. coli vaccines due to vast heterogeneity
06

Interacting drugs

There are no broad-spectrum drugs directly targeting all E. coli surface antigens collectively.

2 more in the full profile.

07

Biomarkers

O antigen serotype (e.g., O157:H7) is widely used for strain identification and epidemiology.K antigen/capsule and specific fimbriae/adhesins can be used as biomarkers for pathogenic E. coli subtypes

Beyond the preview

Go deeper on Escherichia coli surface antigen (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escherichia coli surface antigen (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call